Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension
Go back to Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension| ENDO INTERNAT (NASDAQ: ENDP) | Delayed: 0.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $63.71 | |||
| Open | $0.02 | 52 Week Low | $12.56 | |||
| Day High | $0.29 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $0.00 | |||
| Volume | 24,300 | |||||
| (AMEX: ENDPQ) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $23.32 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 38 | |||||
